首页> 外文期刊>Australian and New Zealand Journal of Obstetrics and Gynecology >Discrepancies between clinical staging and pathological findings of operable cervical carcinoma with stage IB-IIB: a retrospective analysis of 818 patients.
【24h】

Discrepancies between clinical staging and pathological findings of operable cervical carcinoma with stage IB-IIB: a retrospective analysis of 818 patients.

机译:IB-IIB期可手术宫颈癌的临床分期与病理结果之间的差异:818例患者的回顾性分析。

获取原文
获取原文并翻译 | 示例
       

摘要

INTRODUCTION AND OBJECTIVES: Cervical cancer is the only gynaecological cancer that is staged clinically. The clinical stage of cervical cancer relies largely on the pelvic examination. The aim of this study is to analyse the discrepancy between clinical stage and pathological results, and to explore the accuracy of pelvic examination. METHODS: We collected retrospective data from 818 patients with cervical carcinoma staged IB-IIB, who were treated with primary surgery from January 1999 to June 2007. Clinical stages of those patients were determined by pelvic examination without anaesthesia. After surgery, all the patients were assigned to pT category according to the pathological findings. Comparisons were made between these two stages. RESULTS: The total concordance between clinical stage and pT category for stage IB-IIB was 53.1%, with an overestimation of 37.3% and an underestimation of 9.7%. The concordance in stage IB1, stage IB2, stage IIA and stage IIB were 85.4%, 77.4%, 35.3% and 20.5%, respectively. The most significant discrepancy was caused by the failure to detect the parametrial invasion accurately in stage IIB. The accuracy of pelvic examination to determine vaginal and parametrial disease was 70.2% and 74.0%, respectively. CONCLUSIONS: There are significant discrepancies between clinical stage and pathological results. Pelvic examination has its limitations in staging determination. Thus for operable cervical cancer, clinical stage alone is not reliable for selecting postoperative therapies and surgical staging system may be considered.
机译:简介和目的:宫颈癌是唯一在临床上进行的妇科癌症。子宫颈癌的临床阶段主要取决于骨盆检查。这项研究的目的是分析临床分期与病理结果之间的差异,并探讨骨盆检查的准确性。方法:我们收集了1999年1月至2007年6月接受818例分期IB-IIB宫颈癌的患者的回顾性数据。这些患者的临床分期是通过不进行麻醉的骨盆检查确定的。手术后,根据病理结果将所有患者分为pT类。在这两个阶段之间进行了比较。结果:IB-IIB期的临床分期与pT类别之间的总一致性为53.1%,其中高估了37.3%,而低估了9.7%。 IB1,IB2,IIA和IIB期的一致性分别为85.4%,77.4%,35.3%和20.5%。最显着的差异是由于在IIB期未能准确检测到子宫旁膜浸润引起的。盆腔检查确定阴道和子宫旁疾病的准确性分别为70.2%和74.0%。结论:临床分期与病理结果之间存在显着差异。骨盆检查在分期确定方面有其局限性。因此,对于可手术的宫颈癌,仅临床阶段对于选择术后治疗是不可靠的,可以考虑手术分期系统。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号